Day One Biopharmaceuticals Inc

NASDAQ DAWN

Download Data

Day One Biopharmaceuticals Inc Market Capitalization on June 03, 2024: USD 1.15 B

Day One Biopharmaceuticals Inc Market Capitalization is USD 1.15 B on June 03, 2024, a 8.76% change year over year. Market capitalization is a financial metric that represents the total value of a publicly traded company. It is calculated by multiplying the current share price of a company by the total number of outstanding shares. Market capitalization is used to assess the size and relative value of a company in the stock market. It provides investors with an idea of the company's overall worth and is often used as a basis for comparing companies within the same industry or sector. A higher market capitalization generally indicates a larger, more established company.
  • Day One Biopharmaceuticals Inc 52-week high Market Capitalization is USD 1.56 B on May 01, 2024, which is 35.06% above the current Market Capitalization.
  • Day One Biopharmaceuticals Inc 52-week low Market Capitalization is USD 1.38 M on February 21, 2024, which is -99.88% below the current Market Capitalization.
  • Day One Biopharmaceuticals Inc average Market Capitalization for the last 52 weeks is USD 1.17 B.
NASDAQ: DAWN

Day One Biopharmaceuticals Inc

CEO Dr. Jeremy Bender M.B.A., Ph.D.
IPO Date May 27, 2021
Location United States
Headquarters 395 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Employees 174
Sector Healthcare
Industry Biotechnology
Description

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.

Similar companies

ABOS

Acumen Pharmaceuticals Inc

USD 2.75

-6.46%

ELDN

Eledon Pharmaceuticals Inc

USD 2.80

1.82%

StockViz Staff

September 8, 2024

Any question? Send us an email